Bayer Inc. v. Dr. Reddy's Laboratories Ltd.

Bayer Inc. v. Dr. Reddy's Laboratories Ltd.

Motion dismissed because adding Dr. Reddy to the common September 2020 hearing would add complexity and risk preventing the court from determining the earlier actions within the 24-month regulatory timeframe; a full separate trial for Dr. Reddy within the statutory period is a reasonable alternative and outweighs the efficiencies of joinder.

Citation
2019 FC 1408
Parties
Plaintiff: Bayer Inc.; Plaintiff: Bayer Intellectual Property GmbH; Defendant: Dr. Reddy's Laboratories Ltd.; Defendant: Dr. Reddy's Laboratories Limited; Defendant: Dr. Reddy's Laboratories, Inc.
Court
Federal Court
Jurisdiction
Canada
Judgment Date
12 November 2019
Procedural Posture
Action Under the Patented Medicines (notice of Compliance) Regulations / Case Management Motion to Join Common Hearing of Invalidity Issues / Pre Trial
Outcome
Motion dismissed, without costs.
Legal Topics
Invalidity, Joinder, Consolidation, Pm(noc) Regulations, Costs
Source Language
English
Patent Law Administrative Law Civil Procedure Invalidity Joinder Consolidation Pm(noc) Regulations Costs

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Legal principles 5 Authorities cited 4 Party arguments 2
Sign in to unlock

Parties

Bayer Inc.

Plaintiff

Bayer Intellectual Property GmbH

Plaintiff

Dr. Reddy's Laboratories Ltd.

Defendant

Dr. Reddy's Laboratories Limited

Defendant

Dr. Reddy's Laboratories, Inc.

Defendant

Procedural Posture

Action Under the Patented Medicines (notice of Compliance) Regulations / Case Management Motion to Join Common Hearing of Invalidity Issues / Pre Trial

Legal Issues

  1. 1 Whether Dr. Reddy's should be added to the common trial of invalidity issues scheduled for September 2020
  2. 2 Whether adding Dr. Reddy's would imperil the ability to meet the 24-month determination period mandated by the PM(NOC) Regulations
  3. 3 Whether costs should be awarded and against whom

Ratio Decidendi

Motion dismissed because adding Dr. Reddy to the common September 2020 hearing would add complexity and risk preventing the court from determining the earlier actions within the 24-month regulatory timeframe; a full separate trial for Dr. Reddy within the statutory period is a reasonable alternative and outweighs the efficiencies of joinder.

Court Disposition

Motion dismissed, without costs.

Orders

  • Dr. Reddy’s motion is dismissed, without costs.